8223.HK – Ziyuanyuan Holdings Group

Last Day

Medical Distribution

• Trailing PE:
• Forward PE:
• Price Sales TTM:
• Price Book MRQ:
• Enterprise Value:
• Enterprise Value Revenue:
• Enterprise Value Ebitda:
• Beta:

• Shares Outstanding:
• Market Capitalization:
• Market Capitalization Mln:
• EBITDA:
• PE Ratio:
• PEG Ratio:
• Wall Street Target Price:
• Book Value:
• Dividend Share:
• Dividend Yield:
• Earnings Share:
• EPS Estimate Current Year:
• EPS Estimate Next Year:
• EPS Estimate Next Quarter:
• EPS Estimate Current Quarter:
• Most Recent Quarter:
• Profit Margin:
• Operating Margin TTM:
• Return On Assets TTM:
• Return On Equity TTM:
• Revenue TTM:
• Revenue Per Share TTM:
• Quarterly Revenue Growth YOY:
• Gross Profit TTM:
• Diluted Eps TTM:
• Quarterly Earnings Growth YOY:

• Type:
• Name:
• Exchange:
• Currency Code:
• Currency Name:
• Currency Symbol:
• Country Name:
• Fiscal Year End:
• IPO Date:
• International Domestic:
• Sector:
• Industry:
• Address:
• Country:
• Listings:
• Web URL:
• Full Time Employees:
• Updated At:
• Gic Sector:
• Gic Group:
• Gic Industry:
• Gic SubIndustry:

Ziyuanyuan Holdings Group Limited, an investment holding company, provides medical equipment finance leasing services in the People’s Republic of China. It operates through Finance Leasing Service; Postpartum Care Services; and Trading Business segments. The company offers sale-leaseback and direct finance leasing services. It also provides maternal and child postpartum care industry services; and money lending services, as well as trades in medical equipment and consumables. Ziyuanyuan Holdings Group Limited was founded in 2014 and is headquartered in Shenzhen, the People’s Republic of China. Ziyuanyuan Holdings Group Limited is a subsidiary of Hero Global Limited. Address: Room A1001, Majialong Innovation Building, Shenzhen, China

The data, information and layout displayed above cannot be used for commercial purpose. We do not accept any liability for reliance of the information above. We can provide detailed description of source data regarding our industry research and valuation research to our clients upon request.